Lasting downregulation of the lipid peroxidation enzymes in the prefrontal cortex of mice susceptible to stress-induced anhedonia

Behavioural Brain Research

Volumn 276, Issue , 2015, Pages 118-129

  Cline, Brandon H ^a,i   Anthony, Daniel C ^b,i   Lysko, Alexander ^c,i   Dolgov, Oleg ^d,i   Anokhin, Konstantin ^d,i   Schroeter, Careen ^e,i   Malin, Dmitry ^c,f,i   Kubatiev, Aslan ^c,i   Steinbusch, Harry W ^h,i   Lesch, Klaus Peter ^g,h,i   Strekalova, Tatyana ^e,h,i,j  

^a CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^d Institute of Normal Physiology   (Russian Federation)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF WISCONSIN   (United States)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^j INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

more..

Author keywords

Anhedonia; Chronic stress depression model; Imipramine; Lipid peroxidation; Microarray; Prefrontal cortex

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; IMIPRAMINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ACUTE STRESS; AGGRESSION; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; C57BL 6 MOUSE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; LIPID PEROXIDATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PREFRONTAL CORTEX; RELAPSE; REMISSION; REWARD; ANIMAL; COPING BEHAVIOR; DRUG EFFECTS; ENZYMOLOGY; FOOD PREFERENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY;

AGGRESSION; ANHEDONIA; ANIMALS; CATALASE; DOWN-REGULATION; FOOD PREFERENCES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; IMIPRAMINE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; SUPEROXIDE DISMUTASE;

EID: 84908570890     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.04.037     Document Type: Article

References (71)

1. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999, 222:236-245.
2. Strekalova T., Steinbusch H.W. Measuring behavior in mice with chronic stress depression paradigm. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:348-361.
3. Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007, 12:913-922.
4. 2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 1991, 77:1-23.
5. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005, 10:900-919.
6. Rezin G.T., Amboni G., Zugno A.I., Quevedo J., Streck E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 2009, 34:1021-1029.
7. Hroudova J., Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 2010, 31:336-342.
8. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001, 64:43-51.
9. Ozcan M.E., Gulec M., Ozerol E., Polat R., Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004, 19:89-95.
10. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007, 22:67-73.
11. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser V., da Silva Vargas R., et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 2007, 421:33-36.
12. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 2006, 31:326-332.
13. Stefanescu C., Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord 2012, 143:34-38.
14. Vargas H.O., Nunes S.O., Pizzo de Castro M., Cristina Bortolasci C., Sabbatini Barbosa D., Kaminami Morimoto H., et al. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 2013, 150:923-930.
15. Fekadu A., Rane L.J., Wooderson S.C., Markopoulou K., Poon L., Cleare A.J. Prediction of longer-term outcome of treatment-resistant depression in tertiary care. Br J Psychiatry 2012, 201:369-375.
16. Christensen T., Bisgaard C.F., Wiborg O. Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression. Neuroscience 2011, 196:66-79.
17. Eren I., Naziroglu M., Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 2007, 32:1188-1195.
18. Kurhe Y., Radhakrishnan M., Gupta D., Devadoss T. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice. J Pharm Pharmacol 2014, 66:122-132.
19. Moretti M., Colla A., de Oliveira Balen G., dos Santos D.B., Budni J., de Freitas A.E., et al. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 2012, 46:331-340.
20. Seo J.S., Park J.Y., Choi J., Kim T.K., Shin J.H., Lee J.K., et al. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J Neurosci 2012, 32:9690-9699.
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
22. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5:247-251.
23. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987, 93:358-364.
24. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
25. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 1991, 88:2088-2092.
26. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
27. Strekalova T., Couch Y., Kholod N., Boyks M., Malin D., Leprince P., et al. Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct 2011, 7:9.
28. Couch Y., Anthony D.C., Dolgov O., Revischin A., Festoff B., Santos A.I., et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun 2013, 29:136-146.
29. Cline B.H., Steinbusch H.W., Malin D., Revishchin A.V., Pavlova G.V., Cespuglio R., et al. The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2. BMC Neurosci 2012, 13:110.
30. Strekalova T., Anthony D.C., Dolgov O., Anokhin K., Kubatiev A., Steinbusch H.M., et al. The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naive mice. Behav Brain Res 2013, 245:101-106.
31. Costa-Nunes J., Zubareva O., Araujo-Correia M., Valenca A., Schroeter C.A., Pawluski J.L., et al. Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressed mice. Stress 2014, 17:108-116.
32. Strekalova T., Spanagel R., Dolgov O., Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 2005, 16:171-180.
33. Markova N., Chernopiatko A., Schroeter C.A., Malin D., Kubatiev A., Bachurin S., et al. Hippocampal gene expression of deiodinases 2 and 3 and effects of 3,5-diiodo-l-thyronine T2 in mouse depression paradigms. BioMed Res Int 2013, 2013:565218.
34. Bailey J.L. Techniques in protein chemistry 1962, Elsevier Pub. Co., Amsterdam, New York.
35. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
36. Cohen G., Dembiec D., Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970, 34:30-38.
37. Claiborne A. CRC handbook of methods for oxygen radical research 1985, CRC Press, Boca Raton, Florida, USA.
38. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971, 44:276-287.
39. Greenwald R.A. CRC handbook of methods for oxygen radical research 1985, CRC Press, Boca Raton, Florida, USA.
40. Sies H. Oxidative stress: oxidants and antioxidants 1991, Academic Press, London, UK.
41. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
42. Tappel M.E., Chaudiere J., Tappel A.L. Glutathione peroxidase activities of animal tissues. Comp Biochem Physiol B 1982, 73:945-949.
43. Beutler E., Blume K.G., Kaplan J.C., Lohr G.W., Ramot B., Valentine W.N. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol 1977, 35:331-340.
44. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
45. Zhang D., Wen X.S., Wang X.Y., Shi M., Zhao Y. Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress. J Ethnopharmacol 2009, 123:55-60.
46. Zafir A., Ara A., Banu N. Invivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:220-228.
47. Wang C., Wu H.M., Jing X.R., Meng Q., Liu B., Zhang H., et al. Oxidative parameters in the rat brain of chronic mild stress model for depression: relation to anhedonia-like responses. J Membr Biol 2012, 245:675-681.
48. Freitas A.E., Bettio L.E., Neis V.B., Santos D.B., Ribeiro C.M., Rosa P.B., et al. Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog Neuropsychopharmacol Biol Psychiatry 2014, 50:143-150.
49. Novio S., Nunez M.J., Amigo G., Freire-Garabal M. Effects of fluoxetine on the oxidative status of peripheral blood leucocytes of restraint-stressed mice. Basic Clin Pharmacol Toxicol 2011, 109:365-371.
50. Budni J., Zomkowski A.D., Engel D., Santos D.B., dos Santos A.A., Moretti M., et al. Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp Neurol 2013, 240:112-121.
51. Popa-Wagner A., Mitran S., Sivanesan S., Chang E., Buga A.M. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev 2013, 2013:963520.
52. Mello B.S., Monte A.S., McIntyre R.S., Soczynska J.K., Custodio C.S., Cordeiro R.C., et al. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 2013, 47:1521-1529.
53. Abelaira H.M., Reus G.Z., Ribeiro K.F., Steckert A.V., Mina F., Rosa D.V., et al. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model. Neurosci Res 2013, 75:324-330.
54. Garg R., Kumar A. Possible role of citalopram and desipramine against sleep deprivation-induced anxiety like-behavior alterations and oxidative damage in mice. Indian J Exp Biol 2008, 46:770-776.
55. Alcocer-Gomez E., de Miguel M., Casas-Barquero N., Nunez-Vasco J., Sanchez-Alcazar J.A., Fernandez-Rodriguez A., et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun 2014, 36:111-117.
56. Rawdin B.J., Mellon S.H., Dhabhar F.S., Epel E.S., Puterman E., Su Y., et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 2013, 31:143-152.
57. Kim H.K., Andreazza A.C., Yeung P.Y., Isaacs-Trepanier C., Young L.T. Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J Psychiatry Neurosci 2014, 39:130155.
58. Steckert A.V., Valvassori S.S., Moretti M., Dal-Pizzol F., Quevedo J. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 2010, 35:1295-1301.
59. Reus G.Z., Stringari R.B., de Souza B., Petronilho F., Dal-Pizzol F., Hallak J.E., et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev 2010, 3:325-331.
60. Abdel-Salam O.M., Salem N.A., Hussein J.S. Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice. Neurotox Res 2012, 21:245-255.
61. Anisman H., Du L., Palkovits M., Faludi G., Kovacs G.G., Szontagh-Kishazi P., et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 2008, 33:131-141.
62. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1:214-216.
63. de Morais H., de Souza C.P., da Silva L.M., Ferreira D.M., Werner M.F., Andreatini R., et al. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behav Brain Res 2014, 258:52-64.
64. Liu Y., Jia G., Gou L., Sun L., Fu X., Lan N., et al. Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress. Pharmacol Biochem Behav 2013, 104:27-32.
65. Della F.P., Abelaira H.M., Reus G.Z., Santos M.A., Tomaz D.B., Antunes A.R., et al. Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats. Metab Brain Dis 2013, 28:93-105.
66. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:676-692.
67. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin N Am 2009, 29:247-264.
68. Campbell S.J., Perry V.H., Pitossi F.J., Butchart A.G., Chertoff M., Waters S., et al. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol 2005, 166:1487-1497.
69. Zoppi S., Madrigal J.L., Caso J.R., Garcia-Gutierrez M.S., Manzanares J., Leza J.C., et al. Regulatory role of the cannabinoid-2 receptor in stress-induced neuroinflammation in mice. Br J Pharmacol 2014, [Epub ahead of print]. 10.1111/bph.12607.
70. Kalueff A.V., Stewart A.M. Modeling neuropsychiatric spectra to empower translational biological psychiatry. Behav Brain Res 2014.
71. Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.